Warmuth Markus
President & CEO
SaleAlert
- Shares
- 9,500
- Price
- $23.18
- Value
- $220,219
SEC EDGAR · Forms 3/4/5Updated through Oct 30, 2026•41 filings
GLUE
Monte Rosa Therapeutics, Inc.
No net buying or selling imbalance over the last 3 months
No net buyers or sellers account for the net balance. There is no cluster of three distinct buyers within 30 days. We found no CEO/CFO purchases over 12 months.
How to read this signal
Only open-market P purchases and S sales count toward the signal. Vesting, options, taxes and gifts remain in the source data but do not trigger alerts. Rule 10b5-1 trades are shown as informational.
3-month balance
$0.00
0 buyers · 0 sellers
12-month purchases
$0.00
0 distinct insiders
12-month sales
$3,755,911
7 distinct insiders
Highlighted alerts
8
21 Rule 10b5-1 trades treated as informational
Buying cluster · 30 days
Fewer than three distinct buyers
CEO/CFO purchases · 12 months
No executive purchases found
Get GLUE insider trades by API
The same filtered trades as JSON for your scripts, alerts or AI agent, for 5,500+ US companies — plus sentiment, news, financials and breakout setups. Free · every API · 1,000 requests a month · no card required.
GLUE overview: breakout setup, X sentiment and insiders in one page →
Form 4 raw → Raspberry
The value is in what we do not call a signal.
The SEC XML stores every transaction. Raspberry keeps that evidence, reads the footnotes and separates voluntary open-market activity from vesting, option exercises, gifts, tax withholding, stock purchase and dividend reinvestment plans and pre-programmed 10b5-1 trades.
93
Raw transactions
Everything returned by the filing
29
Voluntary view
P/S trades after deterministic checks
61
Administrative noise
Stored, never alerted
47
10b5-1
Shown as informational
SEC ownership XML facts
- Code
- S
- Shares
- 13
- Price
- $10.56
- Footnotes
- 1
Represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. These sales were automatic and not in the discretion of the Reporting Person.
Raspberry interpretation
Informational — no alert
Reason: tax_withholding. The filing footnotes identify tax withholding.
Recent transactions
Voluntary purchases and sales; administrative noise stays hidden.
Champoux Jennifer
Chief Operating Officer
Sale 10b5-1
- Shares
- 4,351
- Price
- $23.38
- Value
- $101,730
Townson Sharon
Chief Scientific Officer
Sale 10b5-1
- Shares
- 400
- Price
- $24.13
- Value
- $9,652
Townson Sharon
Chief Scientific Officer
Sale 10b5-1
- Shares
- 5,600
- Price
- $23.25
- Value
- $130,197
Janku Filip
Chief Medical Officer
Sale 10b5-1
- Shares
- 5,407
- Price
- $24.50
- Value
- $132,472
Janku Filip
Chief Medical Officer
Sale 10b5-1
- Shares
- 6,000
- Price
- $22.95
- Value
- $137,700
Manning Anthony M.
Director
SaleAlert
- Shares
- 10,000
- Price
- $23.11
- Value
- $231,100
Janku Filip
Chief Medical Officer
Sale 10b5-1
- Shares
- 30,000
- Price
- $21.42
- Value
- $642,681
Janku Filip
Chief Medical Officer
Sale 10b5-1
- Shares
- 11,845
- Price
- $20.22
- Value
- $239,522
Townson Sharon
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,000
- Price
- $20.00
- Value
- $60,000
Champoux Jennifer
Chief Operating Officer
Sale 10b5-1
- Shares
- 2,175
- Price
- $20.00
- Value
- $43,500
Champoux Jennifer
Chief Operating Officer
Sale 10b5-1
- Shares
- 2,176
- Price
- $19.00
- Value
- $41,344
Townson Sharon
Chief Scientific Officer
Sale 10b5-1
- Shares
- 3,000
- Price
- $19.00
- Value
- $57,000
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 468
- Price
- $19.73
- Value
- $9,232
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 4,998
- Price
- $19.41
- Value
- $97,021
Townson Sharon
Chief Scientific Officer
Sale 10b5-1
- Shares
- 6,000
- Price
- $19.87
- Value
- $119,220
Champoux Jennifer
Chief Operating Officer
Sale 10b5-1
- Shares
- 2,175
- Price
- $20.00
- Value
- $43,500
Champoux Jennifer
Chief Operating Officer
Sale 10b5-1
- Shares
- 2,176
- Price
- $19.00
- Value
- $41,344
Manning Anthony M.
Director
SaleAlert
- Shares
- 10,000
- Price
- $18.01
- Value
- $180,100
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 5,467
- Price
- $18.92
- Value
- $103,447
Warmuth Markus
President & CEO
SaleAlert
- Shares
- 8,000
- Price
- $17.64
- Value
- $141,125
Nickson Philip
Chief Business & Legal Officer
SaleAlert
- Shares
- 5,845
- Price
- $17.69
- Value
- $103,413
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 5,466
- Price
- $17.92
- Value
- $97,974
Dunn Edmund
Principal Accounting Officer
SaleAlert
- Shares
- 536
- Price
- $17.50
- Value
- $9,380
Dunn Edmund
Principal Accounting Officer
SaleAlert
- Shares
- 25,164
- Price
- $18.10
- Value
- $455,506
Janku Filip
Chief Medical Officer
SaleAlert
- Shares
- 9,189
- Price
- $19.50
- Value
- $179,161
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 309
- Price
- $24.57
- Value
- $7,593
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 1,450
- Price
- $23.88
- Value
- $34,620
Warmuth Markus
President & CEO
Sale 10b5-1
- Shares
- 3,707
- Price
- $23.24
- Value
- $86,159
| Date | Insider | Transaction | Shares | Price | Value | Reading |
|---|---|---|---|---|---|---|
| Jul 16, 2026 | Warmuth Markus President & CEO | Sale | 9,500 | $23.18 | $220,219 | |
| Jul 15, 2026 | Champoux Jennifer Chief Operating Officer | Sale | 4,351 | $23.38 | $101,730 | |
| Jul 06, 2026 | Townson Sharon Chief Scientific Officer | Sale | 400 | $24.13 | $9,652 | |
| Jul 06, 2026 | Townson Sharon Chief Scientific Officer | Sale | 5,600 | $23.25 | $130,197 | |
| Jun 30, 2026 | Janku Filip Chief Medical Officer | Sale | 5,407 | $24.50 | $132,472 | |
| Jun 29, 2026 | Janku Filip Chief Medical Officer | Sale | 6,000 | $22.95 | $137,700 | |
| Jun 29, 2026 | Manning Anthony M. Director | Sale | 10,000 | $23.11 | $231,100 | |
| Jun 24, 2026 | Janku Filip Chief Medical Officer | Sale | 30,000 | $21.42 | $642,681 | |
| Jun 23, 2026 | Janku Filip Chief Medical Officer | Sale | 11,845 | $20.22 | $239,522 | |
| Jun 23, 2026 | Townson Sharon Chief Scientific Officer | Sale | 3,000 | $20.00 | $60,000 | |
| Jun 23, 2026 | Champoux Jennifer Chief Operating Officer | Sale | 2,175 | $20.00 | $43,500 | |
| Jun 17, 2026 | Champoux Jennifer Chief Operating Officer | Sale | 2,176 | $19.00 | $41,344 | |
| Jun 17, 2026 | Townson Sharon Chief Scientific Officer | Sale | 3,000 | $19.00 | $57,000 | |
| Jun 01, 2026 | Warmuth Markus President & CEO | Sale | 468 | $19.73 | $9,232 | |
| Jun 01, 2026 | Warmuth Markus President & CEO | Sale | 4,998 | $19.41 | $97,021 | |
| May 29, 2026 | Townson Sharon Chief Scientific Officer | Sale | 6,000 | $19.87 | $119,220 | |
| May 27, 2026 | Champoux Jennifer Chief Operating Officer | Sale | 2,175 | $20.00 | $43,500 | |
| May 22, 2026 | Champoux Jennifer Chief Operating Officer | Sale | 2,176 | $19.00 | $41,344 | |
| May 21, 2026 | Manning Anthony M. Director | Sale | 10,000 | $18.01 | $180,100 | |
| May 01, 2026 | Warmuth Markus President & CEO | Sale | 5,467 | $18.92 | $103,447 | |
| Apr 14, 2026 | Warmuth Markus President & CEO | Sale | 8,000 | $17.64 | $141,125 | |
| Apr 09, 2026 | Nickson Philip Chief Business & Legal Officer | Sale | 5,845 | $17.69 | $103,413 | |
| Mar 02, 2026 | Warmuth Markus President & CEO | Sale | 5,466 | $17.92 | $97,974 | |
| Mar 02, 2026 | Dunn Edmund Principal Accounting Officer | Sale | 536 | $17.50 | $9,380 | |
| Feb 27, 2026 | Dunn Edmund Principal Accounting Officer | Sale | 25,164 | $18.10 | $455,506 | |
| Feb 23, 2026 | Janku Filip Chief Medical Officer | Sale | 9,189 | $19.50 | $179,161 | |
| Jan 07, 2026 | Warmuth Markus President & CEO | Sale | 309 | $24.57 | $7,593 | |
| Jan 07, 2026 | Warmuth Markus President & CEO | Sale | 1,450 | $23.88 | $34,620 | |
| Jan 07, 2026 | Warmuth Markus President & CEO | Sale | 3,707 | $23.24 | $86,159 |
“Alert” means a voluntary, unscheduled transaction according to the filing; it is not an investment recommendation. Official source: SEC EDGAR.